Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aalberts stock logo
AALBF
Aalberts
$30.19
$33.29
$28.65
$45.38
N/AN/A1,396 shsN/A
BVII
(BVII)
$0.00
$0.03
$0.10
N/AN/A3,442 shsN/A
Shionogi & Co., Ltd. stock logo
SGIOF
Shionogi & Co., Ltd.
$15.20
$15.15
$12.21
$16.66
N/AN/A1,358 shsN/A
TDCH
30DC
$0.00
$0.00
$0.07
N/AN/A30,535 shsN/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aalberts stock logo
AALBF
Aalberts
0.00%0.00%-14.66%-14.53%-33.59%
Shionogi & Co., Ltd. stock logo
SGIOF
Shionogi & Co., Ltd.
0.00%0.00%-1.36%+7.10%-69.35%
TDCH
30DC
0.00%0.00%0.00%0.00%-99.63%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aalberts stock logo
AALBF
Aalberts
0.0954 of 5 stars
0.00.01.70.00.90.80.0
BVII
(BVII)
N/AN/AN/AN/AN/AN/AN/AN/A
Shionogi & Co., Ltd. stock logo
SGIOF
Shionogi & Co., Ltd.
N/AN/AN/AN/AN/AN/AN/AN/A
TDCH
30DC
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aalberts stock logo
AALBF
Aalberts
0.00
N/AN/AN/A
BVII
(BVII)
0.00
N/AN/AN/A
Shionogi & Co., Ltd. stock logo
SGIOF
Shionogi & Co., Ltd.
0.00
N/AN/AN/A
TDCH
30DC
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aalberts stock logo
AALBF
Aalberts
N/AN/AN/AN/AN/AN/A
BVII
(BVII)
N/AN/AN/AN/AN/AN/A
Shionogi & Co., Ltd. stock logo
SGIOF
Shionogi & Co., Ltd.
N/AN/AN/AN/AN/AN/A
TDCH
30DC
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aalberts stock logo
AALBF
Aalberts
N/A$1.2723.83N/AN/AN/AN/A5/2/2025 (Estimated)
BVII
(BVII)
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Shionogi & Co., Ltd. stock logo
SGIOF
Shionogi & Co., Ltd.
N/A$90.940.17N/AN/AN/AN/A5/12/2025 (Estimated)
TDCH
30DC
N/A-$0.01N/AN/AN/AN/AN/AN/AN/A

Latest SGIOF, BVII, TDCH, and AALBF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2025N/A
Aalberts stock logo
AALBF
Aalberts
$1.53N/AN/AN/A$1.59 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aalberts stock logo
AALBF
Aalberts
$0.351.15%N/A27.50%N/A
BVII
(BVII)
N/AN/AN/AN/AN/A
Shionogi & Co., Ltd. stock logo
SGIOF
Shionogi & Co., Ltd.
$19.10125.65%N/A21.00%N/A
TDCH
30DC
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Aalberts stock logo
AALBF
Aalberts
46.99%
BVII
(BVII)
N/A
Shionogi & Co., Ltd. stock logo
SGIOF
Shionogi & Co., Ltd.
22.59%
TDCH
30DC
0.08%

Insider Ownership

CompanyInsider Ownership
Aalberts stock logo
AALBF
Aalberts
N/A
BVII
(BVII)
N/A
Shionogi & Co., Ltd. stock logo
SGIOF
Shionogi & Co., Ltd.
N/A
TDCH
30DC
18.33%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aalberts stock logo
AALBF
Aalberts
14,055N/AN/ANot Optionable
BVII
(BVII)
147,000N/AN/ANot Optionable
Shionogi & Co., Ltd. stock logo
SGIOF
Shionogi & Co., Ltd.
5,690N/AN/ANot Optionable
TDCH
30DC
10N/AN/ANot Optionable

Recent News About These Companies

30DC Inc
Garmin discount codes for June 2023
Tech Deals & Buying Guides
Everyday Tech
Tech News
Tech BLOGS
TEXAS TECH RED RAIDERS NEWS
TECH POLICY

Media Sentiment Over Time

Aalberts stock logo

Aalberts OTCMKTS:AALBF

$30.19 0.00 (0.00%)
As of 04/28/2025

Aalberts N.V. offers mission-critical technologies for aerospace, automotive, building, and maritime sectors. It operates through Building Technology and Industrial Technology sectors. The Building Technology segment develops, manufactures, and monitors hydronic flow control systems for heating and cooling to enhance the energy efficiency; and develops, designs, and manufactures integrated piping systems to distribute and regulate water or gas flows in heating, cooling, water, gas, and sprinkler systems in eco-friendly buildings and industrial niches. The Industrial Technology segment co-develops, engineers, and manufactures advanced mechatronics and technologies to regulate, measure, and control fluids under severe and critical conditions for active OEMs in semicon efficiency, sustainable transportation, and industrial niches; and offers a range of surface technologies utilizing a network of service locations local knowledge to customers active in sustainable transportation and industrial niches. It operates in Western Europe, the United States, Russia, Eastern Europe, the Asia-Pacific, the Middle East, and Africa. The company was formerly known as Aalberts Industries N.V. and changed its name to Aalberts N.V. in April 2019. Aalberts N.V. was founded in 1975 and is headquartered in Utrecht, the Netherlands.

(BVII) OTCMKTS:BVII

Broadview Institute, Inc. is a career-focused post-secondary education services company. The Company operates primarily through its subsidiary, C Square Educational Enterprises, Inc. (Broadview University). Broadview University has campuses located in the Utah cities of Layton, Orem, Salt Lake City and West Jordan, as well as Boise, Idaho. Broadview University is accredited by the Accrediting Council for Independent Colleges and Schools (ACICS) to award diplomas, undergraduate degrees, and master's degrees in various fields of study. The Company's admissions department interviews potential applicants, provides information regarding its academic programs, and assists with the overall application process. The Company helps its students to complete their program of study through admissions screening, financial planning and student services. The Company's classes are offered in the day and evening, and many courses are available through online delivery. It also provides assistance.

Shionogi & Co., Ltd. stock logo

Shionogi & Co., Ltd. OTCMKTS:SGIOF

$15.20 0.00 (0.00%)
As of 04/28/2025

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug. It also develops S-872600 an influenza nasal vaccine; S-875670 anCOVID-19 nasal vaccine; S-540956 a nucleic acid adjuvant; S-554110 a nontuberculous mycobacterial infection; S-337395 for RSV infections; S-892216 for COVID-19 therapeutics; Olorofim for invasive aspergillosis; cefiderocol for aerobic gram-negative bacterial infections and infectious diseases; S-268019 a COVID-19 prophylactic vaccine; S-268019 a prophylactic vaccine for COVID-19; ensitrelvir for COVID-19 treatment and prevention; baloxavir for influenza virus infection; S-365598 for HIV infection; and S-555739 for suppressing aggravation of COVID-19. In addition, the company develops S-540956 for nucleic acid adjuvant; S-109802 for post-stroke spasticity; S-151128 for chronic pain; S-588210 and S-531011 for solid tumor; S-309309 for obesity; BPN14770 for Alzheimer's disease and fragile X syndrome; S-588410 for bladder cancer; S-488210 for head and neck squamous cell carcinoma; S-005151 for Acute ischemic stroke and epidermolysis bullosa; Rizmoic for opioid-induced constipation; ADR-001 for decompensated liver cirrhosis; S-222611 for malignant tumor; S-812217 for depression; GRT7039 for pain associated with osteoarthritis of the knee; SDT-001 for inattentive ADHD; S-588410 for esophageal cancer; SR-0379 for cutaneous ulcer; and S-723595 for type 2 diabetes. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.

30DC OTCMKTS:TDCH

30DC, Inc. provides digital media solutions. The company primarily provides MagCast Publishing Platform, a cloud-based digital publishing software which enables customers to create mobile magazine apps, as well as facilitates the monetization of digital content through advanced marketing functions. It also offers related training courses and support services. The company was founded in 2005 and is based in New York, New York.